MedPath

Relaxation-Response-based Mental Health Promotion - Open and Calm 2013

Not Applicable
Conditions
Stress Psychological
Stress Physiological
Quality of Life
Registration Number
NCT02140307
Lead Sponsor
Steen G Hasselbalch
Brief Summary

The purpose of the study is to investigate health-promoting and stress-reducing psychological, physiological and hormonal effects of a 9-week meditation-based course in personal health and to examine potential baseline factors for any such effects. Thus, the investigators will investigate the course format (individual course or group-based course) as a potential factor the course outcome, and also individual background factors such as demographics and genetic variations.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
72
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Change in scores on Perceived Stress on Cohen's Perceived Stress ScaleFrom baseline to post-treatment (9 weeks later) and to 3-month follow-up

The investigators expect a decrease in perceived stress of significantly larger magnitude in interventional groups than in waitlist controls across the three time points

Cortisol secretion as measured by the cortisol awakening responseFrom baseline to post-treatment (after 9 weeks)

The investigators expect a significant reduction of cortisol secretion in intervention groups and larger than in wait-list controls. Specifically, the investigators analyze the Area Under Curve with respect to Ground (total cortisol output) after awakening. Cortisol was only collected for 2/3 data waves (N = 48) due to logistics.

COMMENT: The investigators have two primary outcomes, but both are measures of stress levels. The investigators expect to see both hormonal and perceived stress improvements.

Secondary Outcome Measures
NameTimeMethod
Change in Pittsburgh Sleep Quality Index (PSQI)From baseline to post-treatment (9 weeks later) and to 3-month follow-up

The investigators expect a larger improvement of sleep quality in the intervention groups than in the wait-list controls over the course of the three time points

Change in Quality of Life on the WHO-5 scaleFrom baseline to post-treatment (9 weeks later) and to 3-month follow-up

The investigators expect a larger improvement in perceived quality of life in intervention groups compared to wait-list controls over the course of the three time points

Change in Short-Form Health Survey-36From baseline to post-treatment (9 weeks later) and to 3-month follow-up

The investigators expect a significantly larger improvement in quality of life (SF-36-Mental Component Summary Score and SF-36 Physical Component Summary Score) in intervention groups compared to wait-list controls over the course of the three time points.

Change in Major Depression InventoryFrom baseline to post-treatment (9 weeks later) and to 3-month follow-up

The investigators expect a significantly larger decrease in depressive symptoms in intervention groups than in wait-list controls over the course of the three time points.

Trial Locations

Locations (1)

Neurobiology Research Unit, dep. 9201, Copenhagen University Hospital (Rigshospitalet)

🇩🇰

Copenhagen OE, Denmark

Neurobiology Research Unit, dep. 9201, Copenhagen University Hospital (Rigshospitalet)
🇩🇰Copenhagen OE, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.